Innovative Alpha-2 Antiplasmin Diagnostic Testing Technologies and Emerging Markets
Innovative Alpha-2 Antiplasmin Diagnostic TestingTechnologies and Emerging MarketsReport Details:Published:November 2012No. of Pages: 195Price: Single User License – US$3850This report contains 195 pages, 8 tables and presents a detailed analysis of the Alpha-2Antiplasmin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan,including clinical significance and current laboratory practice, as well as 5- and 10-year testvolume forecasts by country and market segment.The growing cost-containment pressures in major industrialized nations and continuedtechnological advances will radically change coagulation testing practice during the next ten years.New specific and sensitive markers of hemostasis will be increasingly used on automatedinstrumentation. Coagulation testing in general, and Alpha-2 Antiplasmin testing specifically, willbecome more standardized, offering opportunities for quality control products and services.Moreover, the continuing contraction of the hospital system and technological advances willfacilitate decentralization of the Alpha-2 Antiplasmin testing closer to the patient, creatingadditional opportunities and challenges for suppliers.The report examines market applications of chromogenic substrates, monoclonal antibodies,immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews featuresand operating characteristics of automated analyzers; profiles leading suppliers and recent marketentrants developing innovative technologies and products; and identifies alternative marketpenetration strategies and entry barriers/risks.Get your copy of this report @http://www.reportsnreports.com/reports/207872-innovative-alpha-2-antiplasmin-diagnostic-testing-technologies-and-emerging-markets-.htmlMajor points covered in Table of Contents of this report includeTable of ContentsI. IntroductionII. Worldwide Market and Technology OverviewA. IntroductionB. Alpha-2 Antiplasmin: Clinical Significance
10. BiosensorsIII. France: Test Volume Forecasts by Market SegmentIV. Germany: Test Volume Forecasts by Market SegmentV. Italy: Test Volume Forecasts by Market SegmentVI. Japan: Test Volume Forecasts by Market SegmentVII. Spain: Test Volume Forecasts by Market SegmentVIII. UK: Test Volume Forecasts by Market SegmentIX. USA: Test Volume Forecasts by Market SegmentX. Design Criteria For Decentralized Testing ProductsXI. Alternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Market1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types Of Distributors7. Market SegmentationXII. Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesXIII. Competitive AssessmentsAbbott
American DiagnosticaAvocet MedicalAxis-ShieldBeckman CoulterBecton DickinsonBio/Data CorporationBiositeChrono-LogCorgenix MedicalDiagnostica StagoHelena LaboratoriesHYPEN BioMedInstrumentation LaboratoryITCNanogenRocheSiemensSiencoSysmexThermo FischerTrinity BiotechZyCareList of TablesMajor Companies Developing or Marketing Alpha-2 Antiplasmin TestsFranceAlpha-2 Antiplasmin Test Volume Forecasts by Market SegmentGermanyAlpha-2 Antiplasmin Test Volume Forecasts by Market SegmentItalyAlpha-2 Antiplasmin Test Volume Forecasts by Market SegmentJapanAlpha-2 Antiplasmin Test Volume Forecasts by Market SegmentSpainAlpha-2 Antiplasmin Test Volume Forecasts by Market SegmentU.K.Alpha-2 Antiplasmin Test Volume Forecasts by Market SegmentU.S.A.Alpha-2 Antiplasmin Test Volume Forecasts by Market Segment
Contact: firstname.lastname@example.org for more information.